Zoledronic acid increases spine bone mass and prevents hip bone loss after bariatric surgery: a randomized placebo-controlled study

Año publicación: 2025

Subir documento: https://onlinelibrary.wiley.com/doi/10.1002/oby.24214

Nombre investigadores: Søren Gam, Simon Lysdahlgaard, Bibi Gram, Martin Weber Kusk, Anne Pernille Hermann, Claus Bogh Juhl, Stinus Gadegaard Hansen